Search
Sunday 31 January 2016
  • :
  • :

Notable Stocks Watch List - Pier 1 Imports Inc (NYSE:PIR), Cytori Therapeutics Inc (NASDAQ:CYTX), Kroger Co (NYSE:KR)

Notable Stocks Watch List – Pier 1 Imports Inc (NYSE:PIR), Cytori Therapeutics Inc (NASDAQ:CYTX), Kroger Co (NYSE:KR)

On Monday, Shares of Pier 1 Imports Inc (NYSE:PIR), gained 6.46% to $5.11.

Park Lane Advisor has initiated coverage on the following equities: Pier 1 Imports Inc. (PIR), The Container Store Group Inc. (TCS), TravelCenters of America LLC (TA), and Marinemax Inc. (HZO). Free research report on Pier 1 Imports can be accessed at http://www.parklaneadvisor.com/ On Friday, December 18, 2015, the NASDAQ Composite ended at 4,923.08, down 1.59%, the Dow Jones Industrial Average declined 2.10%, to finish the day at 17,128.55, and the S&P 500 closed at 2,005.55, down 1.78%. The losses were broad based as all the sectors ended the session in negative. Register for your complimentary reports at the links given below.

On Friday, shares in Pier 1 Imports Inc. recorded a trading volume of 7.90 million shares, higher than their three months average volume of 3.29 million shares. The stock ended the day 1.05% higher at $4.80. Shares of the company traded at a PE ratio of 7.87. Pier 1 Imports Inc.’s stock has plummeted 25.12% in the last one month, 47.28% in the previous three months and 68.08% on YTD basis. The company is trading below its 50-day and 200-day moving averages by 30.68% and 54.30%, respectively. Furthermore, shares of Pier 1 Imports Inc. have a Relative Strength Index (RSI) of 28.58.

Pier 1 Imports, Inc. engages in the retail sale of decorative home furnishings, furniture, gifts, and related items. The company offers decorative accents and textiles, such as rugs, wall decorations and mirrors, pillows, bedding, lamps, vases, dried and artificial flowers, baskets, ceramics, dinnerware, candles, fragrance, gift, and seasonal items.

Shares of Cytori Therapeutics Inc (NASDAQ:CYTX), declined -11.43% to $0.186, during its last trading session.

Cytori Therapeutics, declared that it has reached definitive agreements with certain holders (the “Consenting Holders”) of about 100% of its outstanding Series A-1 and A-2 warrants issued in May and August of 2015 in addition to warrants issued in October 2014. The agreements are intended to improve the financial flexibility of the Company, reduce the fully diluted share count, remove potentially dilutive effects of certain warrant provisions that offered for resets in warrant exercise price in potential future transactions, and provide greater freedom for the Company to use its ATM or ”at-the-market offering” program. If all warrant holders elect to engage in these cashless exercises, the Company will issue an aggregate of about 36.5 million common shares following such exercises.

Dr. Marc H. Hedrick, President and Chief Executive Officer of the Company said, “We believe that these warrant exercises are mutually beneficial to both our stockholders and Cytori. In terms of our financials, these exercises simplify our balance sheet and our equity structure. Operationally, we believe these agreements and subsequent warrant exercises will improve our attractiveness to potential commercial partners as we near milestones in our US osteoarthritis and US and European scleroderma programs. On a related note, based on continued success of our expense reduction initiative, we can at this time, update our 2015 operating cash burn guidance for the full year down to $22 million, $3 million less than our initial guidance of $25 million revealed in the startning of 2015.”

Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy compriseing of a heterogeneous population of specialized cells, counting stem cells for the treatment of patients with scleroderma hand dysfunction, orthopedic disorders, cardiovascular disease, urinary incontinence, and thermal burns combined with radiation injury.

Finally, Kroger Co (NYSE:KR), ended its last trade with 1.43% gain, and closed at $41.22.

The Kroger Co. (KR) and Roundy’s, declared the successful completion of Kroger’s tender offer to purchase all outstanding shares of Roundy’s common stock for $3.60 per share in cash. The tender offer expired at 11:59 p.m., Eastern Standard Time, on December 17, 2015.

Kroger anticipates to complete the acquisition of the remaining eligible Roundy’s shares not attained in the tender offer later recently through a merger under Section 251(h) of the General Corporation Law of the State of Delaware.

“This merger blends Roundy’s complementary markets with Kroger’s strengths in scale and merchandising. Our future together is bright, and we look forward to learning from each other as partners,” said Rodney McMullen, Kroger’s chairman and CEO. “Most of all, we want to welcome each of Roundy’s more than 22,000 associates to the Kroger family of stores.”

The Kroger Co., together with its auxiliaries, operates as a retailer in the United States and internationally. It also manufactures and processes food for sale in its supermarkets. The company operates retail food and drug stores, multi-department stores, jewelry stores, and convenience stores.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *